Cargando…

Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states

BACKGROUND: In Nigeria, diarrhea is the second leading killer of children under five. Between 2012-2017, the Clinton Health Access Initiative, Inc. (CHAI) and the Government of Nigeria implemented a comprehensive program in eight states aimed at increasing the percentage of children under five with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lam, Felix, Abdulwahab, Ahmad, Houdek, Jason, Adekeye, Olajumoke, Abubakar, Mohammed, Akinjeji, Adewale, Braimoh, Tiwadayo, Ajeroh, Obinna, Stanley, Melinda, Goh, Nancy, Schroder, Kate, Wiwa, Owens, Ihebuzor, Nnenna, Prescott, Marta Rose
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Edinburgh University Global Health Society 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505637/
https://www.ncbi.nlm.nih.gov/pubmed/31073399
http://dx.doi.org/10.7189/jogh.09.010502
_version_ 1783416796619997184
author Lam, Felix
Abdulwahab, Ahmad
Houdek, Jason
Adekeye, Olajumoke
Abubakar, Mohammed
Akinjeji, Adewale
Braimoh, Tiwadayo
Ajeroh, Obinna
Stanley, Melinda
Goh, Nancy
Schroder, Kate
Wiwa, Owens
Ihebuzor, Nnenna
Prescott, Marta Rose
author_facet Lam, Felix
Abdulwahab, Ahmad
Houdek, Jason
Adekeye, Olajumoke
Abubakar, Mohammed
Akinjeji, Adewale
Braimoh, Tiwadayo
Ajeroh, Obinna
Stanley, Melinda
Goh, Nancy
Schroder, Kate
Wiwa, Owens
Ihebuzor, Nnenna
Prescott, Marta Rose
author_sort Lam, Felix
collection PubMed
description BACKGROUND: In Nigeria, diarrhea is the second leading killer of children under five. Between 2012-2017, the Clinton Health Access Initiative, Inc. (CHAI) and the Government of Nigeria implemented a comprehensive program in eight states aimed at increasing the percentage of children under five with diarrhea who were treated with zinc and oral rehydration solution (ORS). The program addressed demand, supply, and policy barriers to ORS and zinc uptake through interventions in both public and private sectors. The interventions included: (1) policy revision and partner coordination; (2) market shaping to improve availability of affordable, high-quality ORS and zinc; (3) provider training and mentoring; and (4) caregiver demand generation. METHODS: We conducted cross–sectional household surveys in program states at baseline, midline, and endline and constructed logistic regression models with generalized estimating equations to assess changes in ORS and zinc treatment during the program period. RESULTS: In descriptive analysis, we found 38% (95% CI = 34%-42%) received ORS at baseline and 4% (95% CI = 3%-5%) received both ORS and zinc. At endline, we found 55% (95% CI = 51%-58%) received ORS and 30% (95% CI = 27%-33%) received both ORS and zinc. Adjusting for other covariates, the odds of diarrhea being treated with ORS were 1.88 (95% CI = 1.46, 2.43) times greater at endline. The odds of diarrhea being treated with ORS and zinc combined were 15.14 (95% CI = 9.82, 23.34) times greater at endline. When we include the interaction term to investigate whether the odds ratios between the endline and baseline survey were modified by source of care, we found statistically significant results among diarrhea episodes that sought care in the public and private sector. Among cases that sought care in the public sector, the predictive probability of treatment with ORS increased from 57% (95% CI = 50%-65%) to 83% (95% CI = 79%-87%). Among cases that sought care in the private sector, the predictive probability increased from 41% (95% CI = 34%-48%) to 58% (95% CI = 54%-63%). CONCLUSIONS: Use of ORS and combined ORS and zinc for treatment of diarrhea significantly increased in program states during the program period.
format Online
Article
Text
id pubmed-6505637
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Edinburgh University Global Health Society
record_format MEDLINE/PubMed
spelling pubmed-65056372019-05-09 Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states Lam, Felix Abdulwahab, Ahmad Houdek, Jason Adekeye, Olajumoke Abubakar, Mohammed Akinjeji, Adewale Braimoh, Tiwadayo Ajeroh, Obinna Stanley, Melinda Goh, Nancy Schroder, Kate Wiwa, Owens Ihebuzor, Nnenna Prescott, Marta Rose J Glob Health Research Theme 1: Clinton Health Access Initiative BACKGROUND: In Nigeria, diarrhea is the second leading killer of children under five. Between 2012-2017, the Clinton Health Access Initiative, Inc. (CHAI) and the Government of Nigeria implemented a comprehensive program in eight states aimed at increasing the percentage of children under five with diarrhea who were treated with zinc and oral rehydration solution (ORS). The program addressed demand, supply, and policy barriers to ORS and zinc uptake through interventions in both public and private sectors. The interventions included: (1) policy revision and partner coordination; (2) market shaping to improve availability of affordable, high-quality ORS and zinc; (3) provider training and mentoring; and (4) caregiver demand generation. METHODS: We conducted cross–sectional household surveys in program states at baseline, midline, and endline and constructed logistic regression models with generalized estimating equations to assess changes in ORS and zinc treatment during the program period. RESULTS: In descriptive analysis, we found 38% (95% CI = 34%-42%) received ORS at baseline and 4% (95% CI = 3%-5%) received both ORS and zinc. At endline, we found 55% (95% CI = 51%-58%) received ORS and 30% (95% CI = 27%-33%) received both ORS and zinc. Adjusting for other covariates, the odds of diarrhea being treated with ORS were 1.88 (95% CI = 1.46, 2.43) times greater at endline. The odds of diarrhea being treated with ORS and zinc combined were 15.14 (95% CI = 9.82, 23.34) times greater at endline. When we include the interaction term to investigate whether the odds ratios between the endline and baseline survey were modified by source of care, we found statistically significant results among diarrhea episodes that sought care in the public and private sector. Among cases that sought care in the public sector, the predictive probability of treatment with ORS increased from 57% (95% CI = 50%-65%) to 83% (95% CI = 79%-87%). Among cases that sought care in the private sector, the predictive probability increased from 41% (95% CI = 34%-48%) to 58% (95% CI = 54%-63%). CONCLUSIONS: Use of ORS and combined ORS and zinc for treatment of diarrhea significantly increased in program states during the program period. Edinburgh University Global Health Society 2019-06 2018-02-15 /pmc/articles/PMC6505637/ /pubmed/31073399 http://dx.doi.org/10.7189/jogh.09.010502 Text en Copyright © 2019 by the Journal of Global Health. All rights reserved. http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Research Theme 1: Clinton Health Access Initiative
Lam, Felix
Abdulwahab, Ahmad
Houdek, Jason
Adekeye, Olajumoke
Abubakar, Mohammed
Akinjeji, Adewale
Braimoh, Tiwadayo
Ajeroh, Obinna
Stanley, Melinda
Goh, Nancy
Schroder, Kate
Wiwa, Owens
Ihebuzor, Nnenna
Prescott, Marta Rose
Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states
title Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states
title_full Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states
title_fullStr Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states
title_full_unstemmed Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states
title_short Program evaluation of an ORS and zinc scale-up program in 8 Nigerian states
title_sort program evaluation of an ors and zinc scale-up program in 8 nigerian states
topic Research Theme 1: Clinton Health Access Initiative
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6505637/
https://www.ncbi.nlm.nih.gov/pubmed/31073399
http://dx.doi.org/10.7189/jogh.09.010502
work_keys_str_mv AT lamfelix programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT abdulwahabahmad programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT houdekjason programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT adekeyeolajumoke programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT abubakarmohammed programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT akinjejiadewale programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT braimohtiwadayo programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT ajerohobinna programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT stanleymelinda programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT gohnancy programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT schroderkate programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT wiwaowens programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT ihebuzornnenna programevaluationofanorsandzincscaleupprogramin8nigerianstates
AT prescottmartarose programevaluationofanorsandzincscaleupprogramin8nigerianstates